Marmara Üniversitesi
Istanbul, Kadıköy, 34722, Turkey (Türkiye)
NCT Number: NCT06903390
Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients.
The main questions this study aims to answer are:
What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels.
Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care.
A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety.
This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care.
This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Istanbul, Kadıköy, 34722, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This QPL-based communication intervention stands out with the following key features:
Patient-Centered & Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety.
Structured Training & Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits.
Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation.
RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care.
Focus on Empowerment & Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS).
These features differentiate this intervention by offering a structured, culturally relevant approach.
Time frame: Immediately before the first consultation and within 1 day after the second and third consultations
Assessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.
Time frame: Immediately before the first consultation and within 1 day after the second and third consultations
Measured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.
Marmara University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07582666
Affect (Mental Function), Anxiety
Bellinzona, Canton Ticino, Switzerland
View Trial DetailsNCT07460570
Neoplasms, Neoplasms (Cancer / Tumors)
Muscat, Oman
View Trial DetailsNCT07445243
Behavior, Cancer-related Fatigue
Taichung, Taiwan
View Trial DetailsNCT07704307
Geriatric Oncology, Neoplasms
View Trial Details